HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

E-Cigarette Workshops Aim To Fill Information Gaps Prior To FDA Regulation

This article was originally published in The Tan Sheet

Executive Summary

The first of three workshops, Dec. 10-11, will focus on device designs, liquid nicotine and other ingredients, aerosol constituents, packaging, constituent labeling and environmental impact. The workshops are not for commenting on a proposed rule deeming cigars, pipe tobacco and electronic nicotine delivery devices subject to FDA’s authority.

You may also be interested in...



Ambitious Schedule For OTC Monograph Updates On FDA Unified Agenda

Nearly two-thirds of FDA’s planned regulatory actions for the consumer health segment would update the OTC drug monograph, including changes to pediatric cough/cold labeling, acetaminophen dosing, oral care products with benzocaine and labeling for some laxatives.

CBD Firm Targeting Veterans, Military Takes Broadside On COVID Claims From US Agencies

FTDA and FTC warn Patriot Supreme about noncompliant claims on its website and social media pages promoting CBD to prevent or treat infections from the coronavirus. However, a release Patriot Supreme distributed in July promoting CBD as a COVID-19 remedy remains in online circulation.

US Firms’ Reducing Allergy Claims For Infant Nutritionals Scratch FDA's Enforcement Discretion

“To the extent these claims pertain to the ingestion of peanuts, they are not consistent with the claim in the [2017] Letter of Enforcement Discretion FDA issued in response to a petition for a qualified health claim for ground peanuts and reduced risk of developing peanut allergy,” state CFSAN officials.

Topics

UsernamePublicRestriction

Register

OM013057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel